[HTML][HTML] Diabetic neuropathic pain: physiopathology and treatment
AK Schreiber, CFM Nones, RC Reis… - World journal of …, 2015 - ncbi.nlm.nih.gov
Diabetic neuropathy is a common complication of both type 1 and type 2 diabetes, which
affects over 90% of the diabetic patients. Although pain is one of the main symptoms of …
affects over 90% of the diabetic patients. Although pain is one of the main symptoms of …
Capsaicin in metabolic syndrome
Capsaicin, the major active constituent of chilli, is an agonist on transient receptor potential
vanilloid channel 1 (TRPV1). TRPV1 is present on many metabolically active tissues …
vanilloid channel 1 (TRPV1). TRPV1 is present on many metabolically active tissues …
Current evidence to propose different food supplements for weight loss: A comprehensive review
M Watanabe, R Risi, D Masi, A Caputi, A Balena… - Nutrients, 2020 - mdpi.com
The use of food supplements for weight loss purposes has rapidly gained popularity as the
prevalence of obesity increases. Navigating through the vast, often low quality, literature …
prevalence of obesity increases. Navigating through the vast, often low quality, literature …
Localized neuropathic pain: an expert consensus on local treatments
G Pickering, E Martin, F Tiberghien… - Drug Design …, 2017 - Taylor & Francis
Background Pain localization is one of the hallmarks for the choice of first-line treatment in
neuropathic pain. This literature review has been conducted to provide an overview of the …
neuropathic pain. This literature review has been conducted to provide an overview of the …
[Retracted] Capsaicin Alleviates Vascular Endothelial Dysfunction and Cardiomyopathy via TRPV1/eNOS Pathway in Diabetic Rats
Q Wang, C Zhang, C Yang, Y Sun… - … Medicine and Cellular …, 2022 - Wiley Online Library
Background. Endothelial dysfunction and cardiomyopathy are considered to be important
vascular complications associated with diabetes. This study was designed to investigate …
vascular complications associated with diabetes. This study was designed to investigate …
A pharmacological treatment algorithm for localized neuropathic pain
M Allegri, R Baron, G Hans… - … medical research and …, 2016 - Taylor & Francis
Neuropathic pain is caused by a lesion or disease affecting the somatosensory system and
is difficult to manage, often proving refractory to existing treatments. In more than half of …
is difficult to manage, often proving refractory to existing treatments. In more than half of …
Neuropathic pain modeling: Focus on synaptic and ion channel mechanisms
Animal models of pain consist of modeling a pain-like state and measuring the consequent
behavior. The first animal models of neuropathic pain (NP) were developed in rodents with a …
behavior. The first animal models of neuropathic pain (NP) were developed in rodents with a …
Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific
BS Rafanan Jr, BF Valdecañas, BP Lim… - Pain …, 2018 - Taylor & Francis
Osteoarthritis prevalence is expected to increase markedly in the Asia-Pacific region due to
rapid population aging. Identifying effective and safe therapeutic options to manage …
rapid population aging. Identifying effective and safe therapeutic options to manage …
Recent progress in gels for neuropathic pain
Neuropathic pain is a complex and debilitating condition that affects millions of people
worldwide. While several treatment options are available, they often have limited efficacy …
worldwide. While several treatment options are available, they often have limited efficacy …
Flavonoids as potential therapeutic agents for the management of diabetic neuropathy
Flavonoids are secondary metabolites that are widely distributed in plants. These phenolic
compounds are classified into various subgroups based on their structures: flavones …
compounds are classified into various subgroups based on their structures: flavones …